In HCC, CD13 interacts with HDAC5 (histone deacetylase 5) to promote its protein stability, thus resulting in HDAC5-mediated LSD1 (lysine-specific demethylase 1) deacetylation and protein stabilization. Here, HDAC5 is linked to hepatocellular carcinoma.